Skip to main content
Equibles

Graham Cooper

Board Member

Beam Therapeutics Inc. (BEAM)

Chairman

Kezar Life Sciences, Inc.

Equibles does not estimate personal net worth.

Get an email with a short summary when Beam Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get BEAM alerts

About Graham Cooper

Graham Cooper is recorded as Board Member at Beam Therapeutics Inc. (BEAM) and Chairman at Kezar Life Sciences, Inc. since May 12, 2022. The newest filing on record that lists Graham Cooper as Board Member at Beam Therapeutics Inc. (BEAM) is dated April 17, 2026. Kezar Life Sciences, Inc. reported in an 8-K filed May 11, 2026 that Graham Cooper resigned as board of directors of the Company, effective May 11, 2026. Beam Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Kezar Life Sciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Beam Therapeutics Inc. includes John Evans (CEO, Chief Accounting Officer and Board Member), Sravan Emany (CFO), Sravan K. Emany (CFO) and 6 others.

“Pursuant to the terms of the Merger Agreement, at the Effective Time, each of John Fowler, Franklin Berger, Graham Cooper, Elizabeth Garner, M.D., Michael Kauffman, M.D., Ph.D., Micki Klearman, M.D. and Courtney Wallace resigned from the board of directors of the Company.”
Kezar Life Sciences, Inc. Form 8-K, filed May 11, 2026 · Read the filing

Affiliation history

  • Kezar Life Sciences, Inc.

    Chairman

    SEC 8-K

    Current

    2022-05-12–present

  • Beam Therapeutics Inc. (BEAM)

    Board Member

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 17, 2026

  • Kezar Life Sciences, Inc.

    Board Member

    Proxy statement

    2017-01-01–2026-05-11

Company network

Kezar Life Sciences, Inc.

Current role

Biotechnology · Healthcare

Chairman

2017-01-01–present

Leadership on record at Beam Therapeutics Inc.

Recent activity